特发性多毛症与代谢状态:一项基于人群的前瞻性队列研究
该研究基于德黑兰脂质与葡萄糖研究,纳入334例特发性多毛症(IH)女性和1226例健康对照女性,采用广义估计方程分析代谢指标的纵向趋势,并用Cox回归评估IH与代谢紊乱的关联。结果显示,除2型糖尿病(T2DM)在未调整模型中关联边缘显著(HR 1.45,95%CI 1.00-2.11,P=0.05)外,IH与代谢指标变化及代谢紊乱风险无显著差异,调整混杂因素后T2DM关联亦消失。作者据此认为不推荐对IH女性常规筛查这些代谢结局。
要点
- IH女性较健康对照有更低SHBG和更高总睾酮、游离雄激素指数、雄烯二酮及硫酸脱氢表雄酮。
- IH女性与健康对照的FBS、HDL-C、LDL-C、非HDL-C、TG、SBP、DBP及WC纵向平均变化无显著差异。
- 未调整Cox模型中仅T2DM风险边缘显著(HR 1.45,95%CI 1.00-2.11,P=0.05),调整后无显著差异。
核心结论
- IH女性与健康对照相比,代谢危险因素随时间平均变化及心血管代谢结局无显著差异,仅T2DM呈边缘显著差异,进一步调整潜在混杂因素后消失。
- 作者据此认为不推荐对IH女性常规筛查这些代谢结局。
研究设计与样本
- 基于人群的前瞻性研究,从德黑兰脂质与葡萄糖研究中选取334例IH女性和1226例健康对照女性。
- 采用广义估计方程分析两组代谢指标的纵向趋势,并用未调整和调整Cox回归模型评估IH与代谢紊乱的关联。
- 调整模型纳入年龄、体重指数、吸烟、体力活动、高血压病史和糖尿病家族史等潜在混杂因素。
主要发现
- IH女性较健康对照有更低SHBG和更高总睾酮(中位数[IQR]:0.37[0.16-0.70] vs 0.33[0.14-0.58],P=0.01)。
- IH女性较健康对照有更高游离雄激素指数(中位数[IQR]:0.85[0.38-1.54] vs 0.54[0.26-0.97],P=0.001)、雄烯二酮(中位数[IQR]:1.60[1.00-2.25] vs 1.10[0.90-1.70],P=0.001)和硫酸脱氢表雄酮(中位数[IQR]:168.5[91.1-227.8] vs 125.2[66.3-181],P=0.001)。
- IH女性与健康对照的FBS、HDL-C、LDL-C、非HDL-C、TG、SBP、DBP及WC随时间平均变化无显著差异。
- 未调整Cox模型中,除T2DM(HR[95%CI]:1.45[1.00-2.11],P=0.05)外,IH与健康对照在高血压、高血压前期、T2DM前期及代谢综合征风险上无统计学显著差异。
- 调整Cox模型显示上述结局风险均无显著差异。
临床怎么用
- 作者认为不推荐对IH女性常规筛查这些代谢结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A limited number of studies have investigated the impact of idiopathic hirsutism (IH) on cardiometabolic parameters with contradictory and inconclusive results. This study aimed to explore the effect of IH on metabolic outcomes. METHOD: In this population-based prospective study, 334 women with IH and 1226 women as healthy controls were selected from Tehran Lipid and Glucose Study. The generalized estimation equations method was applied to investigate the secular longitudinal trends of metabolic indices, including fasting blood sugar (FBS), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL), non-HDL, triglyceride (TG), systolic blood pressure (SBP), diastolic blood pressure (DBP), and waist circumference (WC) in both groups. Unadjusted and adjusted Cox regression models were applied to assess the hazard ratios (HR) and 95% CIs for the association between IH and metabolic disorders. Potential confounding factors such as age, body mass index, smoking, physical activity, history of hypertension (HTN), and family history of diabetes were included in the adjusted model. RESULTS: This study showed that compared with healthy controls, women with IH had lower SHBG and higher total testosterone (median [interquartile ratio; IQR]: 0.37 [0.16-0.70] vs 0.33 [0.14-0.58]; P = 0.01), free androgen index (median [IQR]: 0.85 [0.38-1.54] vs 0.54 [0.26-0.97]; P = 0.001), androstenedione (median [IQR]: 1.60 [1.00-2.25] vs 1.10 [0.90-1.70]; P = 0.001), and dehydroepiandrosterone sulfate (median [IQR]: 168.5 [91.1-227.8] vs 125.2 [66.3-181]; P = 0.001). Over time, mean changes of FBS, HDL-C, LDL-C, non-HDL-C, TG, SBP, DBP, and WC were not significantly different in women with IH, compared with healthy controls. According to the unadjusted Cox regression model, except for type 2 diabetes mellitus (T2DM) (HR [95% CI]: 1.45 [1.00-2.11]) P = 0.05; there was no statistically significant difference in hazard of metabolic disorders (ie, HTN, pre-HTN, pre-T2DM, and metabolic syndrome) in IH, compared with healthy controls. Besides, the adjusted Cox regression model showed no significant differences in the hazard of these outcomes. CONCLUSION: This study showed no significant difference in overtime mean changes of metabolic risk factors and cardiometabolic outcomes in women with IH, compared with the healthy control group, except marginally significant difference on T2DM, which disappeared after further adjustment for potential confounders. Accordingly, routine screening of women for these metabolic outcomes should not recommend.
引用
- Mahmoudieh L, Amiri M, Rahmati M, et al. Idiopathic Hirsutism and Metabolic Status: A Population-based Prospective Cohort Study. J Clin Endocrinol Metab. 2022. PMID: 36125321. doi:10.1210/clinem/dgac538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。